bacitracin-methylenedisalicylic-acid and Body-Weight

Hybrid male turkeys were fed to 18 wk of age in a completely randomized design with 10 replicate pens (18 birds each) per treatment to compare growth promoters. Four dietary treatments were used: negative control (CON), bacitracin methylene disalicyate (BMD) at 55 mg/kg to 6 wk and 27.5 mg/kg thereafter, mannan oligosaccharide (MOS) at 0.1% to 6 wk and 0.05% thereafter, and BMD and MOS at concentrations listed above. There were 3 toms/m2 (3.59 ft2/tom) on fresh pine shavings inoculated with used litter. A 6-phase feeding program was used, with crumbles the first 3 wk and pellets thereafter. At wk 6 and 18, one bird per pen was killed, and the large intestinal microbial populations, after being frozen, were enumerated (i.e., bifidobacteria, Clostridium perfringens, coliforms, enterococci, Escherichia coli, lactobacilli, and total anerobes). Body weights at wk 18 were as follows: CON, 11.87 kg; BMD, 12.46 kg; MOS: 12.56 kg; and BMD + MOS, 12.79 kg. The BMD and MOS turkeys were (P < 0.05) heavier than CON birds, and those fed the combination were significantly heavier than all other treatments. At wk 18, BMD + MOS feed conversion ratio of 2.66 was significantly lower than CON at 3.00 with BMD and MOS being intermediate (2.83 and 2.79, respectively). Mortality was not affected by treatment. The BMD and MOS each reduced large intestinal concentrations of Clostridium perfringens (log transformed data analysis) at wk 6 but not at wk 18. The BMD or MOS each improved turkey performance, and when used together, exhibited further beneficial effects.

Topics: Animal Nutritional Physiological Phenomena; Animals; Bacitracin; Body Weight; Clostridium perfringens; Hybridization, Genetic; Intestines; Mannans; Mortality; Oligosaccharides; Salicylates; Turkeys

The search constantly continues to identify potential alternatives to the use of antimicrobial growth promoters (AGP) in broiler production. This trial was conducted with broiler chicks to investigate the effect of different levels of Pulicaria gnaphalodes powder (PGP) in comparison with AGP, and probiotic (PRO) on growth performance, gut microflora, intestinal morphology, antioxidant enzyme activity, and fatty acid profile of meat. Ross 308 male broiler chicks (n = 576) were randomly assigned into 6 dietary treatments with 8 replicate pens per treatment and 12 birds per pen. The dietary treatments consisted of a basal diet as control (CON, with no additive), CON + 0.1% PGP, CON + 0.2% PGP, CON + 0.3% PGP, CON + 0.1% probiotic mixture (PRO), and CON + 0.05% bacitracin methylene disalicylate (AGP). Higher body weight gain and lower feed conversion ratio were obtained in birds fed AGP and 0.3% PGP compared with those fed CON and 0.1% PGP during grower, finisher, and the entire study (P < 0.05). On day 42, birds on PRO, 0.2 and 0.3% PGP treatments had lower counts of Escherichia coli and higher lactobacillus spp. in ileum and cecal contents compared to the CON and 0.1% PGP (P < 0.05). Villus height and villus height to crypt depth ratio of the duodenum were increased (P < 0.05) in response to dietary AGP, PRO, and 0.3% PGP. The diets containing PRO and different levels of PGP increased superoxide dismutase and glutathione peroxidase activities and decreased malondialdehyde level in serum, liver, and thigh muscle (P < 0.05). Total polyunsaturated fatty acid and n-3 fatty acid of birds fed PRO and PGP diets were higher than birds in CON and AGP groups (P < 0.05). In summary, supplementation of PGP could be a potential alternative to AGP in broiler diets due to its combined positive impacts on performance, serum cholesterol, intestinal health, antioxidant activity, and fatty acid profile in meat. Such effects, however, need to be further verified under compromised health or a disease challenge condition.

Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Antioxidants; Bacitracin; Body Weight; Chickens; Cholesterol; Diet; Fatty Acids; Gastrointestinal Microbiome; Glutathione Peroxidase; Male; Malondialdehyde; Meat; Probiotics; Pulicaria; Salicylates; Superoxide Dismutase

The intestinal gut health is one of the primary determinants of broiler growth and performance. Among the various enteric diseases, necrotic enteritis (NE) is an enterotoxemic disease caused by Clostridium perfringens, which can result in severe economic losses in poultry farming. Antibiotics like bacitracin methylene disalicylate (BMD) and avilamycin (AVL) are commonly used antibiotic growth promoters (AGP) in poultry feed to control necrotic enteritis in birds. Bacillus subtilis PB6 was reported to prevent necrotic enteritis and improve performance in birds. This paper investigated the influence of Bacillus subtilis PB6 in improving the performance of broiler birds in comparison with BMD and avilamycin. A 35 day trial was conducted with 240 day-old commercial broiler chicks (VenCobb 400), which were divided into four treatment groups, where each treatment group was composed of 6 replicates each containing 10 birds, for a total of 60 birds per treatment. The treatment groups included a negative control (no AGP), Bacillus subtilis PB6, BMD, and avilamycin. The parameters analyzed included body weight, feed conversion ratio (FCR), mortality, villus histomorphometry, and European efficiency factor (EEF). Bacillus subtilis PB6 significantly (P < 0.05) improved body weight and FCR (8 points) compared to the control. The group supplemented with B. subtilis PB6 or BMD had higher (P < 0.05) body weight compared to all other treatment groups. The supplementation of B. subtilis PB6 significantly improved the villus height (P < 0.05) compared to control and other AGP groups. The EEF was found to be the highest in the B. subtilis PB6 supplemented group at 35th day as compared to other treatment groups. The combined data from this study indicate that supplementation of B. subtilis PB6 improves overall performance of broilers compared to BMD and avilamycin, and can be used as potential AGP replacement in poultry farming.

Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Body Weight; Chickens; Diet; Energy Metabolism; Female; Intestines; Longevity; Male; Oligosaccharides; Probiotics; Random Allocation; Salicylates

Day-old Cobb broiler breeder pullets were randomly allotted into 20 floor pens where they were brooded and reared to 23 wk of age. Eight pens received a control diet containing no growth promotant. The other 12 were fed 55 mg of bacitracin methylene disalicylate/kg of diet. Males were reared separately on the control diet. Pullets were full-fed for the first 8 wk of life, then placed on a skip-a-day program with breeder-recommended feed allocations. At 23 wk of age bird numbers were reduced to 26 females per pen, three males added, and diets changed to the layer regimen. Levels of 0, 27.5, 55, or 110 mg/kg of zinc bacitracin were each assigned to five pens with factorial attention to growing treatment. Layer treatments were continued for 280 days. No significant differences were associated with the feeding of bacitracin methylene disalicylate among body weight or mortality data summarized at 8 and 23 wk. Eight-week feed efficiency was also not affected. In the laying phase, 110 mg/kg of zinc bacitracin significantly improved egg production and fertility over the unsupplemented controls. Hatch of fertile eggs, overall hatchability, and the number of chicks per pen were all significantly improved by 27.5 mg/kg of zinc bacitracin. Higher drug levels supported no additional improvement. Feed efficiency, mortality rate, and final body weight were not significantly influenced by any level of supplementation. No effect of grower treatment upon subsequent layer performance was noted.

Topics: Animal Feed; Animals; Bacitracin; Body Weight; Chickens; Coccidiostats; Diet; Eating; Eggs; Female; Fertility; Male; Oviposition; Random Allocation; Salicylates

A buffered propionic acid (BPA) was added to broiler diets fed in floor pens with litter. The BPA was fed continuously at 0, .2, .4, and .8% in Trial 1 and at 0 and .4% in Trial 2. The BPA was also fed at .4% for the last 7 days in Trial 2. Natural salmonellae exposure versus periodic dosage with Salmonella typhimurium was compared in Trial 2. In Trial 1, the BPA supplement had no adverse effects on growth, feed utilization, or abdominal fat with a significant (P less than or equal to .05) increase in the female dressing value at .8% of buffered propionic acid. The total number of coliforms and of Escherichia coli in the duodenum were significantly reduced by .4% BPA; in the jejunum, by all levels used in the trials; and in the ileum, by .4% and .8% of buffered propionic acid. The intestinal pH was not influenced by the BPA addition. In Trial 2, the BPA at .4% fed continuously had no adverse effect on growth, feed utilization, the abdominal fat of females, or the dressing percentage of males while significantly reducing the abdominal fat for males and increasing the dressing percentage for females. Feeding .4% BPA for the last 7 days had no effect on any of these parameters. Periodic dosage with S. typhimurium had no effect on body weight, feed utilization, or abdominal fat and significantly increased the dressing percentage. There was a significant interaction between the Salmonella dosage and the time of feeding BPA on dressing percentage.(ABSTRACT TRUNCATED AT 250 WORDS)

Topics: Animals; Bacitracin; Body Weight; Buffers; Chickens; Coccidiostats; Diet; Enterobacteriaceae; Female; Food Microbiology; Intestines; Male; Meat; Propionates; Random Allocation; Roxarsone; Salicylates

Six trials were conducted at different locations to examine the response of broiler chickens to roxarsone and bacitracin in the form of bacitracin methylene disalicylate (BMD) in the presence of the anticoccidal narasin. All diets contained narasin (80 mg/kg) and were fortified with a factorial arrangement of roxarsone (0 to 50 mg/kg) and BMD (0 or 55 mg/kg). Broilers were grown to market weights with narasin and roxarsone removed from the diets for the final 5 days. Addition of both roxarsone and BMD resulted in significant (P less than .05) improvements in body weight and feed utilization. Response to roxarsone for feed utilization was influenced to some extent by the presence or absence of BMD. Although the response to roxarsone was always positive, the degree of response was lessened by the presence of BMD. This resulted in a significant (P less than .10) interaction between roxarsone and BMD for feed utilization but not for body weight.

Topics: Animal Feed; Animals; Arsenicals; Bacitracin; Body Weight; Chickens; Coccidiostats; Female; Food Additives; Male; Pyrans; Roxarsone; Salicylates

Two experiments were conducted to evaluate the response of broiler chickens to addition of bacitracin methylene disalicylate (BMD) to diets containing salinomycin. In each experiment, five tests were conducted at different locations. In Experiment 1, all diets contained 66 mg salinomycin/kg of diet for the first 42 days and either 0 or 33 mg BMD/kg of diet for the entire 49-day feeding period. In Experiment 2, all diets contained 66 mg salinomycin and 50 mg roxarsone/kg of diet for the first 42 days and either 0, 11, 33, or 55 mg BMD/kg of diet for the entire 49-day feeding period. In Experiment 1, addition of 33 mg BMD/kg of diet significantly (P less than .05) improved body weights and feed utilization. Results were similar in all five tests. In Experiment 2, addition of 11, 33, or 55 mg BMD/kg of diet significantly (P less than .05) increased body weights. In one location the addition of 55 mg BMD/kg of diet resulted in no significant difference in body weight compared with those fed the unsupplemented diet, but in all other locations the response was similar. Addition of 33 or 55 mg BMD/kg of diet resulted in improved (P less than .05) feed utilization when all tests were combined. Feed utilization was not improved in all locations by the addition of BMD.

Topics: Animal Feed; Animals; Anti-Bacterial Agents; Arsenicals; Bacitracin; Body Weight; Chickens; Diet; Drug Therapy, Combination; Pyrans; Roxarsone; Salicylates

Three experiments were conducted to determine the effect of receiving diets containing alfalfa meal and certain feed additives on performance of comingled feeder pigs transported 900 to 1,100 km. In Exp. 1, the inclusion of 9.4% dehydrated alfalfa meal in receiving diets for 2 wk resulted in no difference (P greater than .1) in gain or feed conversion from purchase to market compared with pigs fed a basal corn-soybean meal (CS) diet or a diet containing 20% ground whole oats (O). In Exp. 2, pigs fed receiving diets containing 10% dehydrated alfalfa meal had no improvement (P greater than .1) in gain (.60 vs .61 kg/d) or conversion (3.25 vs 3.17) compared with CS-fed pigs. In Exp. 3, pigs fed a receiving diet for 2 wk containing 10% mid-bloom alfalfa ate more (P less than .002) feed daily for 2 wk (.82 vs .76 kg) and overall (P less than .04; 1.92 vs 1.85 kg) and had an improved (P less than .03) daily gain from purchase to market (.61 vs .59 kg) compared with CS-fed pigs. In Exp. 2, pigs fed diets containing 44 mg/kg tylosin (T) gained similar to pigs fed no additive (O) and slower (P less than .01) than pigs fed 110 mg/kg chlortetracycline (CTC; .59, .60 and .63 kg/d), with no significant differences in feed to gain conversion (3.12, 3.23 and 3.18).(ABSTRACT TRUNCATED AT 250 WORDS)

Topics: Animal Feed; Animals; Bacitracin; Body Weight; Chlortetracycline; Diarrhea; Female; Food Additives; Leucomycins; Male; Medicago sativa; Salicylates; Swine; Swine Diseases; Transportation; Tylosin

A 32-week experiment was carried out in floor pens with Cobb X Cobb breeder pullets that were 28 weeks old at initiation. Ten replicate pens, each containing 13 pullets and 2 males, received one of four dietary treatments. These treatments were either an unmedicated feed or 27.5, 55, or 110 mg/kg of bacitracin methylene disalicylate (BMD). All feeds contained 13.2 mg/kg of hygromycin B. Feed was allocated at a rate of 159 g per day and water was provided continuously. Hen-day egg production was significantly improved by the feeding of 27.5 mg/kg or more of BMD. Egg weights were significantly lower for all groups receiving the drug. Eggs of birds receiving 110 mg/kg were significantly heavier than those produced with 27.5 mg/kg, but neither differed statistically from those of the 55 mg/kg group. Neither final body weight nor overall mortality was significantly related to treatment. Egg fertility was significantly improved by 27.5 mg/kg or more of BMD. Hatchability of fertile eggs was not affected by the drug, but total hatchability was significantly increased through BMD feeding, largely on the strength of improved fertility.

Topics: Animals; Bacitracin; Body Weight; Chickens; Female; Fertility; Food Additives; Male; Mortality; Oviposition; Reproduction; Salicylates

A total of 879 broiler strain chickens ranging from 2 1/2- to 7 1/2 weeks of age was utilized in four battery experiments to determine whether Roxarsone and/or bacitracin MD added to halofuginone were compatible and beneficial in reducing the effects of coccidial infections. The additives were generally beneficial as measured by weight gain and feed efficiency but not as measured by other parameters such as dropping score, lesion score, or oocyst production. The addition of 200 g of bacitracin/ton of feed did not give an additional response above that from 50 g/ton. Roxarsone in the ration was more effective in younger chickens (2 1/2 week old) than older ones (6 weeks, 2 days and 7 weeks, 3 days).

Topics: Animals; Arsenicals; Bacitracin; Body Weight; Chickens; Coccidiosis; Coccidiostats; Drug Combinations; Eimeria; Feeding Behavior; Piperidines; Poultry Diseases; Quinazolines; Quinazolinones; Roxarsone; Salicylates